Items where authors include "Muthana, M."

Article

Rahman, M.M. orcid.org/0000-0002-2996-8109, Wells, G., Rantala, J.K. et al. (3 more authors) (2024) In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges. Expert Review of Clinical Immunology. ISSN 1744-666X

Hapuarachi, B., Danson, S. orcid.org/0000-0002-3593-2890, Wadsley, J. orcid.org/0000-0002-1499-1277 et al. (1 more author) (2023) Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Frontiers in Immunology, 14. 1335256. ISSN 1664-3224

Gao, Z., Mansor, M.H., Winder, N. et al. (4 more authors) (2023) Microfluidic-assisted ZIF-silk-polydopamine nanoparticles as promising drug carriers for breast cancer therapy. Pharmaceutics, 15 (7). 1811. ISSN 1999-4923

Winder, N., Ashraf, Z., Gohar, S. et al. (4 more authors) (2023) Are mild cleansers appropriate for hand hygiene in the COVID era? An in vitro investigation of the antiviral efficacy of different hand hygiene products. Frontiers in Virology, 3. 1180815. ISSN 2673-818X

Tazzyman, S., Stewart, G.R., Yeomans, J. orcid.org/0000-0002-9546-3600 et al. (6 more authors) (2023) HSV1716 prevents myeloma cell regrowth when combined with bortezomib in vitro and significantly reduces systemic tumor growth in mouse models. Viruses, 15 (3). 603. ISSN 1999-4915

Patel, P., Alghamdi, A., Shaw, G. et al. (18 more authors) (2023) Development of a personalised device for systemic magnetic drug targeting to brain tumours. Nanotheranostics, 7 (1). pp. 102-116. ISSN 2206-7418

Winder, N., Gohar, S. and Muthana, M. orcid.org/0000-0003-2497-8903 (2022) Norovirus: an overview of virology and preventative measures. Viruses, 14 (12). 2811. ISSN 1999-4915

Kwan, A., Howard, F. orcid.org/0000-0001-9899-3079, Winder, N. et al. (13 more authors) (2022) Macrophage delivered HSV1716 is active against triple negative breast cancer. Future Pharmacology, 2 (4). pp. 444-459. ISSN 2673-9879

Howard, F.H.N. orcid.org/0000-0001-9899-3079, Kwan, A., Winder, N. et al. (3 more authors) (2022) Understanding immune responses to viruses—do underlying Th1/Th2 cell biases predict outcome? Viruses, 14 (7). 1493.

Howard, F. orcid.org/0000-0001-9899-3079, Conner, J., Danson, S. orcid.org/0000-0002-3593-2890 et al. (1 more author) (2022) Inconsistencies in modeling the efficacy of the oncolytic virus HSV1716 reveal potential predictive biomarkers for tolerability. Frontiers in Molecular Biosciences, 9. 889395.

Kim, T., Johnston, J., Castillo-Lluva, S. et al. (10 more authors) (2022) TRIB1 regulates tumor growth via controlling tumor-associated macrophage phenotypes and is associated with breast cancer survival and treatment response. Theranostics, 12 (8). pp. 3584-3600.

Howard, F.H.N. orcid.org/0000-0001-9899-3079, Al‐Janabi, H., Patel, P. et al. (11 more authors) (2022) Nanobugs as drugs: bacterial derived nanomagnets enhance tumor targeting and oncolytic activity of HSV‐1 virus. Small, 18 (13). 2104763. ISSN 1613-6810

Iscaro, A., Jones, C., Forbes, N. et al. (10 more authors) (2022) Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus. Nanomedicine: Nanotechnology, Biology and Medicine, 40. 102506. ISSN 1549-9634

Canuas-Landero, V.G., George, C.N., Lefley, D.V. et al. (4 more authors) (2021) Oestradiol contributes to differential antitumour effects of adjuvant zoledronic acid observed between pre- and post-menopausal women. Frontiers in Endocrinology, 12. 749428.

Kwan, A., Winder, N. and Muthana, M. orcid.org/0000-0003-2497-8903 (2021) Oncolytic virotherapy treatment of breast cancer : barriers and recent advances. Viruses, 13 (6). 1128.

Taher, Z., Legge, C., Winder, N. et al. (5 more authors) (2021) Magnetosomes and magnetosome mimics : preparation, cancer cell uptake and functionalization for future cancer therapies. Pharmaceutics, 13 (3). 367.

Müller, L.M.E., Migneco, G., Scott, G.B. et al. (17 more authors) (2021) Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer, 9 (3). e001803. ISSN 2051-1426

Deng, S., Iscaro, A., Zambito, G. et al. (8 more authors) (2021) Development of a new hyaluronic acid based redox-responsive nanohydrogel for the encapsulation of oncolytic viruses for cancer immunotherapy. Nanomaterials, 11 (1). 144.

Sier, V.Q., de Vries, M.R., van der Vorst, J.R. et al. (8 more authors) (2021) Cell-based tracers as Trojan horses for image-guided surgery. International Journal of Molecular Sciences, 22 (2). 755. ISSN 1661-6596

Aldughaim, M.S., Muthana, M. orcid.org/0000-0003-2497-8903, Alsaffar, F. et al. (1 more author) (2021) Specific targeting of PEGylated liposomal doxorubicin (Doxil®) to tumour cells using a novel TIMP3 peptide. Molecules, 26 (1). 100. ISSN 1420-3049

George, C.N., Canuas-Landero, V., Theodoulou, E. et al. (3 more authors) (2020) Oestrogen and zoledronic acid driven changes to the bone and immune environments: potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions. Journal of Bone Oncology, 25. 100317. ISSN 2212-1374

Howard, F. orcid.org/0000-0001-9899-3079 and Muthana, M. orcid.org/0000-0003-2497-8903 (2020) Designer nanocarriers for navigating the systemic delivery of oncolytic viruses. Nanomedicine, 15 (1). pp. 93-110. ISSN 1743-5889

Iscaro, A., Howard, N.F. and Muthana, M. orcid.org/0000-0003-2497-8903 (2019) Nanoparticles: properties and applications in cancer immunotherapy. Current Pharmaceutical Design, 25 (17). pp. 1962-1979. ISSN 1381-6128

Song, W., Gregory, D.A. orcid.org/0000-0003-2489-5462, Al-Janabi, H. et al. (3 more authors) (2019) Magnetic-silk/polyethyleneimine core-shell nanoparticles for targeted gene delivery into human breast cancer cells. International Journal of Pharmaceutics , 555. pp. 322-336. ISSN 0378-5173

Song, W., Muthana, M. orcid.org/0000-0003-2497-8903, Mukherjee, J. et al. (3 more authors) (2017) Magnetic-Silk Core–Shell Nanoparticles as Potential Carriers for Targeted Delivery of Curcumin into Human Breast Cancer Cells. ACS Biomaterials Science & Engineering, 3 (6). pp. 1027-1038. ISSN 2373-9878

Rahat, M.A., Coffelt, S.B., Granot, Z. et al. (2 more authors) (2016) Macrophages and Neutrophils: Regulation of the Inflammatory Microenvironment in Autoimmunity and Cancer. Mediators Inflamm, 2016. 5894347. ISSN 0962-9351

Colley, H.E., Muthana, M., Danson, S.J. et al. (14 more authors) (2015) An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of Medicinal Chemistry, 58 (23). 9309 - 9333. ISSN 0022-2623

Muthana, M., Hawtree, S., Wilshaw, A. et al. (10 more authors) (2015) C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis. Proceedings of the National Academy of Sciences, 112 (37). pp. 11618-11623.

Muthana, M., Kennerley, A.J., Hughes, R. et al. (12 more authors) (2015) Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nature Communications, 6. 8009.

Hawtree, S., Muthana, M., Wilkinson, J.M. et al. (2 more authors) (2015) Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis. Human Molecular Genetics, 24 (19). pp. 5367-5377. ISSN 0964-6906

Tazzyman, S., Murdoch, C., Yeomans, J. et al. (2 more authors) (2014) Macrophage-mediated response to hypoxia in disease. Hypoxia, 2. pp. 185-196.

Ellam, T., Hameed, A., ul Haque, R. et al. (4 more authors) (2014) Vitamin D Deficiency and Exogenous Vitamin D Excess Similarly Increase Diffuse Atherosclerotic Calcification in Apolipoprotein E Knockout Mice. PLOS ONE, 9 (2). e88767. ISSN 1932-6203

Chen, Y-Y., Brown, N.J. orcid.org/0000-0002-2100-1905, Jones, R. et al. (5 more authors) (2014) A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice. Angiogenesis, 17 (1). pp. 207-219. ISSN 0969-6970